RASAL2 and breast cancer: McLaughlin et al. demonstrated that RASAL2 expression is substantially decreased in luminal B breast cancers and low RASAL2 expression correlates with metastasis and poor survival.53 Our analysis extends these findings towards the basal subtype which exhibits a disproportionately increased number of NF1 shallow deletions.